Table 2 Functional enrichment analysis of common genes by GO-terms.

From: RNA-seq transcriptome analysis of breast cancer cell lines under shikonin treatment

Term

Category

Number of genes

%

P value

Genes

Response to unfolded protein

B.P.

5

1.57

1.2 × 10−5

HSPH1, HSPA6, HSPA1A, DNAJB1, HSPA1B, PPP1R15A

Negative regulation of apoptosis

B.P.

6

1.89

6.7 × 10−4

CDKN1A, HMOX1, BAG3, PIM1, UBC, HSPA1A

Negative regulation of programmed cell death

B.P.

6

1.89

7.2 × 10−4

CDKN1A, HMOX1, BAG3, PIM1, UBC, HSPA1A, HSPA1B

Negative regulation of cell death

B.P.

6

1.89

7.2 × 10−4

CDKN1A, HMOX1, BAG3, PIM1, UBC, HSPA1A, HSPA1B

Positive regulation of anti-apoptosis

B.P.

3

0.94

1.6 × 10−3

CDKN1A, DUSP1, HMOX1

Intracellular part

C.C.

25

7.86

3.2 × 10−3

HSPA1A, HSPA1B, SESN2, HSPH1, TSPYL2, SLC25A25, MAP1LC3B, HMOX1, BAG3, ETAA1, SIK1, MAFF, ARC, PIM1, MAP1LC3B2, SNAI1, RND3, CDKN1A, DUSP2, ATF3, DUSP1, CSRNP1, ZFAND2A, UBC, DNAJB1, PPP1R15A

Regulation of cell cycle

B.P.

5

1.57

4.3 × 10−3

CDKN1A, TSPYL2, GADD45G, PIM1, SIK1

Regulation of programmed cell death

B.P.

7

2.20

5.2 × 10−3

CDKN1A, DUSP1, HMOX1, BAG3, PIM1, UBC, HSPA1A, HSPA1B

Regulation of cell death

B.P.

7

2.20

5.3 × 10−3

CDKN1A, DUSP1, HMOX1, BAG3, PIM1, UBC, HSPA1A, HSPA1B

Regulation of transferase activity

B.P.

5

1.57

6.5 × 10−3

CDKN1A, TSPYL2, DUSP2, GADD45G, PIM1

Apoptosis

B.P.

6

1.89

6.8 × 10−3

BAG3, CSRNP1, GADD45G, UBC, TNFSF9, PPP1R15A

Intracellular membrane-bounded organelle

C.C.

21

6.60

7.3 × 10−3

MAFF, ARC, PIM1, HSPA1A, HSPA1B, SESN2, SNAI1, RND3, CDKN1A, TSPYL2, ATF3, DUSP2, DUSP1, SLC25A25, MAP1LC3B, HMOX1, ZFAND2A, CSRNP1, UBC, DNAJB1, SIK1, PPP1R15A

Nucleus

C.C.

16

5.03

8.2 × 10−3

MAFF, PIM1, HSPA1A, HSPA1B, SESN2, SNAI1, CDKN1A, TSPYL2, DUSP2, ATF3, DUSP1, HMOX1, ZFAND2A, CSRNP1, UBC, DNAJB1, SIK1

Intracellular organelle

C.C.

22

6.92

1.2 × 10−2

MAFF, ARC, PIM1, HSPA1A, MAP1LC3B2, HSPA1B, SESN2, SNAI1, RND3, CDKN1A, TSPYL2, ATF3, DUSP2, DUSP1, SLC25A25, MAP1LC3B, HMOX1, ZFAND2A, CSRNP1, UBC, DNAJB1, SIK1, PPP1R15A

Negative regulation of cell growth

B.P.

3

0.94

1.5 × 10−2

CDKN1A, TSPYL2, OSGIN1

Negative regulation of cellular process

B.P.

9

2.83

1.5 × 10−2

CDKN1A, TSPYL2, HMOX1, BAG3, PIM1, UBC, OSGIN1, HSPA1A, HSPA1B, SIK1

Regulation of phosphorus metabolic process

B.P.

5

1.57

1.6 × 10−2

CDKN1A, TSPYL2, DUSP2, GADD45G, PIM1

Negative regulation of cell size

B.P.

3

0.94

1.7 × 10−2

CDKN1A, TSPYL2, OSGIN1

Negative regulation of catalytic activity

B.P.

4

1.26

1.8 × 10−2

CDKN1A, DUSP2, GADD45G, UBC

Cell cycle arrest

B.P.

3

0.94

1.8 × 10−2

CDKN1A, SESN2, PPP1R15A

Cytoplasm

C.C.

19

5.97

2.1 × 10−2

ARC, PIM1, HSPA1A, MAP1LC3B2, HSPA1B, SESN2, RND3, HSPH1, CDKN1A, TSPYL2, SLC25A25, MAP1LC3B, HMOX1, ZFAND2A, BAG3, UBC, ETAA1, DNAJB1, SIK1, PPP1R15A

Negative regulation of growth

B.P.

3

0.94

2.1 × 10−2

CDKN1A, TSPYL2, OSGIN1

Cellular protein metabolic process

B.P.

10

3.14

3.9 × 10−2

DUSP2, DUSP1, MAP1LC3B, BAG3, GADD45G, PIM1, UBC, MAP1LC3B2, DNAJB1, SIK1

  1. B.P., biological process; C.C., cellular component.